Monthly News Roundup - November 2018

FDA Approves Truxima as the First Biosimilar to Rituxan In November, the U.S. Food and Drug Administration (FDA) approved Truxima (rituximab-abbs) injection from Celltrion as the first biosimilar to Rituxan (rituximab) for the treatment of adult...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news